Position in GILD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$49,609,587
+$9,965,058 QoQ
Shares Held
355,956
+10.2% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Capital International, Inc./CA/ holds $919,638,265 across 11 Drug Manufacturers - General names. GILD ranks #5 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
2,009,997 | $396,411,608 | |
| 2 | LLY |
ELI LILLY & Co
|
193,029 | $177,542,283 | |
| 3 | AMGN |
Amgen Inc
|
398,069 | $140,060,577 | |
| 4 | ABBV |
AbbVie Inc.
|
430,429 | $93,614,003 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
355,956 | $49,609,587 | |
| 6 | JNJ |
Johnson & Johnson
|
156,815 | $38,331,858 | |
| 7 | PFE |
Pfizer Inc
|
374,286 | $10,509,950 | |
| 8 | NVO |
Novo Nordisk A S
|
155,415 | $5,711,501 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $49,609,587 | 355,956 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $39,644,529 | 322,996 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $39,724,569 | 357,879 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $30,657,328 | 276,516 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $27,943,589 | 249,385 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $28,838,745 | 312,209 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $21,142,268 | 252,174 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $16,199,232 | 236,106 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $17,207,670 | 234,917 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $15,235,469 | 188,069 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,921,307 | 105,702 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,510,873 | 84,480 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,256,248 | 15,141 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,161,292 | 13,527 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $413,939 | 6,710 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $1,953,705 | 32,863 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $2,755,404 | 37,948 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,796,502 | 82,985 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,056,581 | 87,955 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $7,250,064 | 112,178 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $7,443,297 | 127,760 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $7,631,835 | 120,776 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $10,489,307 | 136,331 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $9,696,970 | 129,708 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||